---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "j95oX16QFW0QErsSLGKIeObWi3GVU2e3921G9exfFQoVJZnETd9qS7tbw8djO9VVx4ZataPuNX1XjB7YIJnOmNH27uH1g/6Sp7Gmg/rOSCz7IhnA4cpDROd4xt78Z6Kvrjn0JXMpT8763c1Mvl2st5vJzlWgJ07c3mPpNt37SWkGLPBsfvfWyES+Cubxy1btWXdQm+t8Rj7N75e4GGY5MxyZassgVV17iDlgvrSJiU3tXG+T5dwSh077O1vM6+otRXjXh+85c2JDah3dIg8SKLOg9rcS8AzG+XUkwEnI+/hFIWFPeuOvNMEhH/lVkvIX;eO841izcqPtvWej4f4wQGw=="
---

